All News

The FDA approved Foundayo, which is an oral glucagon-like peptide-1 receptor agonist, for weight loss.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

Patient-centered tools like the Patient's Global Impression of Change scale better assess symptoms, function, quality of life, and treatment effectiveness.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

Community pharmacists help prevent chronic wounds with early triage, modern dressing guidance, and diabetic foot care.

Mississippi pharmacy thrives by pioneering medication synchronization, medication packs, and clinical services, cutting chaos and boosting patient care.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.

Nonopioid pain relief medications include acetaminophen, nonsteroidal anti-inflammatory drugs, suzetrigine, and adjuvant pain management drugs.

GSK and Spero Therapeutics’ newly approved carbapenem could be a standard of care in adults with complicated urinary tract infections who prefer oral administration.

In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.

Pharmacists help patients stay safe with hydration, medication review, warning signs, and cooling resources.

Expanding pharmacy-based screening through a root-cause lens allows pharmacists to identify early dysfunction and improve outcomes.

Community pharmacies redesign workflows to address insurance barriers and deliver safer, gender-affirming care.

As health care spending and polypharmacy increase, researchers are exploring new ways to deprescribe medications, looking to pharmacists to fill in a gap.

A study examining naloxone sales found that retail OTC sales have been surprisingly limited despite improvements in access.

Pharmacy technicians expand vaccine access by handling inventory, billing, screening, and even injections.

With continued reports of gradually waning efficacy among pneumococcal vaccines, researchers look toward vaccine effectiveness among patients aged 18 to 64 years.

This decision marks a milestone in clinical pharmacy as it targets the underlying autoimmune destruction of pancreatic beta cells.

FDA clears first OTC CGM for children 2 years and older, expanding tracking beyond prescriptions for pediatric populations.

How pharmacists differentiate respiratory diseases at the counter.

Pharmacists close these gaps through screening and prevention for patients.

Independent pharmacies combat daily drug shortages with smarter inventory monitoring and diversified suppliers.

This schedule arrives at a time of unprecedented friction between leading medical societies and federal health agencies.

With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.

In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.